The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant tislelizumab plus oxaliplatin and S-1 for locally advanced Siewert type II esophagogastric junction adenocarcinoma: A prospective multicenter phase II study.
 
Yanzhao Xu
No Relationships to Disclose
 
Peng Su
No Relationships to Disclose
 
Zhenhua Li
No Relationships to Disclose
 
Mingbo Wang
No Relationships to Disclose
 
Shiwang Wen
No Relationships to Disclose
 
Yuefeng Zhang
No Relationships to Disclose
 
Yonggang Zhu
No Relationships to Disclose
 
Junhao Qi
No Relationships to Disclose
 
Bokang Sun
No Relationships to Disclose
 
Wenda Gao
No Relationships to Disclose
 
Haijun Wang
No Relationships to Disclose
 
Yuquan Ma
No Relationships to Disclose
 
Chunyong Su
No Relationships to Disclose
 
Tiecheng Wu
No Relationships to Disclose
 
Ziqiang Tian
No Relationships to Disclose